L

Lihua E. Budde

City Of Hope National Medical Center

ORCID: 0000-0003-1464-5494

Publishes on CAR-T cell therapy research, Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research. 362 papers and 8.4k citations.

PubIndex Score96Top 4%How it's scored

362Publications

8.4kTotal Citations

First publication: 1966First senior author: 2014

CAR-T cell therapy research Lymphoma Diagnosis and Treatment Chronic Lymphocytic Leukemia Research Monoclonal and Polyclonal Antibodies Research Cancer Immunotherapy and Biomarkers

Top publicationsby citations

Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology

John A. Thompson, Jillian L. Scavone, Bryan J. Schneider et al.|Journal of the National Comprehensive Cancer Network|2019

Cited by 560

CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results

Brian G. Till, Oliver W. Press, Michael C. Jensen et al.|Blood|2012

Cited by 530

NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020

John A. Thompson, Anita M. Engh, Bryan J. Schneider et al.|Journal of the National Comprehensive Cancer Network|2020

Cited by 484

Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study

Lihua E. Budde, Nancy L. Bartlett, Laurie H. Sehn et al.|The Lancet Oncology|2022

Cited by 429

Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology

John A. Thompson, Lisa Hang, Bryan J. Schneider et al.|Journal of the National Comprehensive Cancer Network|2022

Cited by 416